Older Adults Are Often Excluded From RCTs of Systemic Treatments for Atopic Dermatitis

December 17th 2020, 2:00pm


Older adults are often at greater risk for adverse events from treatments, but they can also be excluded from randomized controlled trials (RCTs), making it difficult to know if findings are generalizable to this population.

Registry for Children With Severe Asthma Shows Potential in Aiding Drug Trial Design

December 10th 2020, 8:30pm


Investigators concluded that use of a new registry could aid in the recruitment of pediatric subjects with severe asthma and the design of future clinical trials for emerging biologics.

Dr David Pariser Highlights Comorbidities and Treatments in the Pipeline for Atopic Dermatitis

December 10th 2020, 3:00pm


The comorbidities associated with atopic dermatitis can be substantial, and the disease can have a significant burden on quality of life, but new biologics and other future treatments may help, said David Pariser, MD, senior physician at Pariser Dermatology Specialists.

Dr David Pariser Discusses the Significant Burden of Atopic Dermatitis

December 5th 2020, 5:00pm


The financial, physical, and social burdens of atopic dermatitis can be substantial, especially for patients who had the condition as children into adulthood, said David Pariser, MD, senior physician at Pariser Dermatology Specialists and professor at Eastern Virginia Medical School Department of Dermatology.

National Asthma Guidelines Get First Update in 13 Years

December 4th 2020, 8:10pm


Updated guidance in 6 key areas of asthma care focus on improving diagnosis, management, and treatment.

Dr David Pariser Outlines Future Treatment Options of Atopic Dermatitis With Biologics and JAK Inhibitors

November 28th 2020, 1:45pm


As the only biologic on the market, dupilumab has replaced most of the more traditional treatments for atopic dermatitis, said David Pariser, MD, senior physician at Pariser Dermatology Specialists.

Behavior Intervention Can Increase Physical Activity and Improve Asthma Control

November 25th 2020, 2:45pm


Patients with asthma can improve their disease control and sleep quality, while reducing depression and anxiety through a behavior change intervention aimed at increasing their physical activity.

Insurance Expansion Reduced Asthma Emergencies in New York City

November 17th 2020, 2:15pm


Expansion of insurance coverage due to the Affordable Care Act led to a reduction in the use of emergency services for patients with asthma in New York City.

Dupilumab Reduces Pain, Discomfort in Patients With Moderate to Severe Atopic Dermatitis

November 15th 2020, 2:30pm


Dupilumab, with or without topical corticosteroids, significantly reduced pain and discomfort in patients with moderate to severe atopic dermatitis.

Dr Nicola Hanania: Treatment of T2-High Asthma Is Constantly Evolving

November 11th 2020, 3:00pm


Treatment targets include several interleukins, immunoglobulin E, and alarmins, pointed out Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston.